Two Sigma Securities, LLC Soleno Therapeutics Inc Transaction History

Two Sigma Securities, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.14 - $0.23 $1,781 - $2,926	12,724 New	12,724 $2,000
Q1 2022 May 16, 2022	SELL	$0.22 - $0.47 $14,811 - $31,643	-67,326 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.41 - $0.91 $27,603 - $61,266	67,326 New	67,326 $28,000
Q3 2021 Nov 15, 2021	SELL	$0.8 - $1.12 $15,375 - $21,525	-19,219 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$0.97 - $1.32 $18,642 - $25,369	19,219 New	19,219 $22,000
Q1 2018 May 15, 2018	SELL	$1.56 - $2.12 $33,515 - $45,546	-21,484 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$1.39 - $2.73 $29,862 - $58,651	21,484	21,484 $39,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $441M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.